Clinical Trials Logo

Myofascial Pain Syndromes clinical trials

View clinical trials related to Myofascial Pain Syndromes.

Filter by:

NCT ID: NCT00222209 Recruiting - Fibromyalgia Clinical Trials

Clinical Study on Implicit Learning, Comorbidity and Stress Vulnerability in Chronic Functional Pain

Start date: September 2005
Phase: N/A
Study type: Interventional

The project investigates on the role of pain avoidance, comorbidity and stress response for the development of chronic somatic and visceral pain. We, the researchers at University Hospital Mannheim, assume that implicit operant learning of pain sensitization is a central mechanism of the process of pain becoming chronic, which is augmented by fear and by avoidance behaviour. Somatic and psychological comorbidity as well as stress factors are further promoting factors in chronic pain development.

NCT ID: NCT00190866 Completed - Fibromyalgia Clinical Trials

Study of Duloxetine Versus Placebo in the Treatment of Fibromyalgia Syndrome

Start date: June 2005
Phase: Phase 3
Study type: Interventional

To assess the efficacy of Duloxetine compared with placebo in the treatment of pain in patients with Fibromyalgia syndrome, with or without major depressive disorder.

NCT ID: NCT00178945 Completed - Cervical Dystonia Clinical Trials

Botulinum Toxin Type A (Botox) for the Treatment of Cervical Dystonia and Upper Thoracic Muscular Pain

Start date: March 2004
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to investigate the use of injections of Botox (botulinum toxin type A) for the treatment of chronic neck pain. Botox is an approved treatment for patients with cervical dystonia. Cervical dystonia is a chronic condition characterized by involuntary movements of the neck that are often painful. In this study, the response from Botox in patients with neck pain not associated with cervical dystonia will be compared to the pain response in patients with cervical dystonia.

NCT ID: NCT00176163 Completed - Fibromyalgia Clinical Trials

Supporting Effect of Dronabinol on Behavioral Therapy in Fibromyalgia and Chronic Back Pain

Start date: August 2005
Phase: Phase 2
Study type: Interventional

It is known, that a so called "pain memory" usually evolves in chronic pain syndromes which both aggravates the disorder and modifies the patients pain perception. Thus, the principal object of pain therapy is to "delete" this dysfunctional pain memory. The combination of medication, physiotherapy and psychological therapy seems to be the most effective treatment. This study investigates the effect of a concomitant Dronabinol medication (Cannabinoid) on the effectiveness of behavioral therapy. It is hypothesized that the combination of behavioral therapy and Dronabinol will be most effective in deleting the pain memory.

NCT ID: NCT00167271 Completed - Fibromyalgia Clinical Trials

Promoting Health in People With Fibromyalgia

Start date: October 2002
Phase: N/A
Study type: Interventional

Body worn sensors and the Internet can be used to self-monitor daily behavior and promote a healthier lifestyle in women with fibromyalgia.

NCT ID: NCT00151528 Completed - Fibromyalgia Clinical Trials

An Open-Label Trial of Pregabalin in Patients With Fibromyalgia

Start date: January 2005
Phase: Phase 3
Study type: Interventional

The main purpose of this protocol is to evaluate the long-term safety of pregabalin in patients who participated in the previous fibromyalgia Study A0081056 and who wish to receive open-label pregabalin therapy.

NCT ID: NCT00151489 Completed - Fibromyalgia Clinical Trials

Safety and Efficacy Study of Pregabalin in Fibromyalgia

Start date: April 2005
Phase: Phase 3
Study type: Interventional

The purpose of this research study of pregabalin and fibromyalgia is to see if 1. pregabalin reduces the pain of fibromyalgia and if this effect lasts for six months and 2. to see if different dosages work better (reduce pain and mild to no side effects) for different people.

NCT ID: NCT00149240 Completed - Clinical trials for Myofascial Pain Syndromes

Botulinum Toxin Type A (Dysport) Associated With Rehabilitation Treatment in Patients With Primary Myofascial Pain Syndrome

Start date: January 2005
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to determine the effectiveness and safety of one dose of botulinum toxin type A (Dysport) associated with rehabilitation treatment on pain control in patients with a type of back pain called primary myofascial pain syndrome.

NCT ID: NCT00142597 Completed - Fibromyalgia Clinical Trials

Effectiveness of Acupuncture in Relieving Pain Due to Fibromyalgia

Start date: May 2005
Phase: Phase 1/Phase 2
Study type: Interventional

This study will determine the effectiveness of acupuncture versus a placebo in altering brain activity and relieving pain due to fibromyalgia.

NCT ID: NCT00134810 Completed - Clinical trials for Myofascial Pain Syndromes

Study to Assess the Efficacy and Safety of Dysport® in Upper Back Myofascial Pain Syndrome

Start date: March 2005
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating one's type of upper back pain. The study will also examine the side effects of this treatment and its overall effect on one's disorder.